i2010 High Level Group

European Union Member States met for the first time to discuss the future of the i2010 strategy. The i2010 High Level Group held its inaugural meeting on 20 April 2006. The Group was established following a Commission Decision and is composed of one representative per Member State at Director General level. The Group decided to work, as a priority, on Convergence and content issues and on Trust and confidence, and to delegate the continuation of the work on eGovernment, eHealth and eInclusion to specific sub-groups.

The main tasks of the Group will be to discuss strategic ICT policy issues in the context of i2010 and in the wider context of the Lisbon agenda. They will also review the effectiveness of i2010, and give advice on possible improvements and adjustments on i2010 actions, using benchmarking to monitor the i2010 implementation and policy evolution. A work programme will be adopted every year by the group.

There will also be a forum to exchange experiences and views on issues covered by the Lisbon National Reform Plans in the areas covered by i2010.

The Group will be composed of one representative per Member State at Director General level. This Group will be chaired by the Commission and will meet up to three times per year. The Group will be open to observers from candidate and EFTA countries. The i2010 Group is an advisory group and falls under the classification of "experts group".

For further information, please visit: i2010 Portal

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...